Better Therapeutics Inc (BTTX)
Sector • Healthcare Industry • Medical Equipment & Supplies |
Industry • Medical Equipment & Supplies |
Sector • Healthcare |
In thefourth quarter of 2022 earnings season operating deficit echoed some enhancement to $-30.002921 millions, at the Medical Equipment & Supplies company
BTTX recorded fourth quarter of 2022 operating loss of $-8.322 millions
Published Apr 02 2023
Goran Soko / CSIMarket.com Contributer
![Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/Surgery_By_NathanGrohmann_(Own_work)_[[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg)
Now, it's eye-catching that, the emerging growth business could conduct business more cost-effective, then in the similar three months a preceding year. Coming from operating deficit of $-30.002921 millions.
Well, maybe the promising revelation is that, the diminishing Returns have declined to $-8.765 millions, from $-39.785 millions, in the fourth quarter of 2021, this will help the organization on company's long journey to be successful big player in the Healthcare sector.
Even more, the company pointed out also net loss of $-39.76 millions and for the fiscal year 2022, Revenues of $0.00 millions.
Medical Equipment & Supplies The company has decreased it's shortfall per share to $-1.69 from $-3.11 in the preceding fiscal year, while by 0 % from $0.00 millions a year before.
Better Therapeutics Inc is expected to report next financial earnings on May 12, 2023.